Hosted on MSN2d
AI-powered blood test revolutionizes early cancer detection
Breast cancer continues to pose a significant global health challenge as the most commonly diagnosed cancer in women ...
GEN16d
Its Revolutionary Potential as a Liquid Biopsy Sample
This eBook delves into the science behind first-void urine, exploring its composition, collection methods, and the latest ...
technologynetworks3d
Advances in Biomarker Discovery: From Disease Detection to Cure
Biomarkers – measurable biological indicators found in blood, bodily fluids or tissues – reflect changes from normal ...
Medindia13d
Cell-Free DNA in Urine: A New Biomarker for UTUC Detection
Discover how voided urine cfDNA emerges as a promising biomarker for upper tract urothelial carcinoma, offering a less ...
BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction
BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--( - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ...
Too Old to Operate10d
Which Factors Influence Biopsy Approach & Therapy Sequence in Metastatic ER+ Breast Cancer?
Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection
Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward ...
Refractory Follicular Lymphoma Diagnostics Market Trends and Forecasts to 2029 - The Rise of Liquid Biopsy
Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...
Stockhouse12d
BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction
BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver ... will share data highlighting how plasma metabolomics can be applied to lobular breast cancer biomarker ...